Clinical Supply Manufacturing Recources
-
Developmental Testing Of IV Solutions
2/10/2022
As IV-administered drugs proliferate, sponsors must understand the associated regulatory requirements, methodologies for useful/required information, and formulations suitable for administration.
-
Vial Containment Systems For Gene And Cell Therapies
5/24/2024
CZ vial-stopper-seal combinations offer a viable solution for the challenges associated with low-temperature storage of cell therapy drug products.
-
Lifecycle Planning For Containment And Delivery Of Biologics Drug Products
6/20/2024
Read more about trends in the biologics market that could impact the lifecycle strategies for your drug product and steps you can take around drug packaging early in development.
-
Solving Logistic Complexities In The Era Of Personalized Medicine
1/1/2022
Examine how the next generation of therapies is disrupting supply chain logistics and explore solutions for the complexities within cell and gene therapies.
-
Prepping For Commercialization Through Supply Chain Logistics
While cell and gene therapies are bringing new hope to patients experiencing rare and serious diseases, uncover how they're disrupting the biopharma market in new and challenging ways.
-
Packaging And Containment: Get Your Products To Market Faster
Learn more about why focusing on packaging solutions early on can keep development on track, help you meet milestones, and get your product to market faster.
-
Outsourcers Are Feeling Uneasy About Continuity Of Supply
4/14/2022
Find out how COVID-19 complications have picked up from the first year, with more outsourcers experiencing bigger obstacles when it comes to manufacturing, specifically with drug product.
-
A Practical Packaging Components Checklist For Emerging Biotechs
6/20/2024
A proactive approach to packaging development can ultimately ensure a smoother launch. Explore five key considerations when selecting components for your injectable drug product.
-
Optimizing Autologous Cell Therapy Clinical Trials
11/6/2023
Delve into four articles regarding dissecting the critical resources, processes, and key stakeholders essential for the successful completion of an ACT clinical trial.
-
De-Risking Your Bioconjugate's Path To Clinical Manufacturing
9/30/2022
Explore the challenges when moving a bioconjugate candidate from early development to clinic, along with integrated solutions for navigating this growing area of the biopharmaceutical industry.